Tag: global biopharmaceutical company

Global biopharma AGC Biologics acquires commercial facility of AstraZeneca

AGC Biologics, a global biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced the purchase of a state-of-the-art commercial manufacturing facility in Boulder, Colorado USA.  The facility, formerly owned by AstraZeneca, will provide AGC Biologics with additional capacity and significantly larger production scale. The facility is expected to begin full-scale operations and manufacturing by April 2021.…

Global pharma AbbVie completes acquisition of Allergan

AbbVie, a research-based global biopharmaceutical company, headquartered in North Chicago, announced that it has completed its acquisition of Allergan plc. “We are pleased to reach this important milestone for the Company, its employees, shareholders and the patients we serve,” said Richard A. Gonzalez, Chairman and Chief Executive Officer, AbbVie. “Our new Allergan colleagues should be commended…